World's Best Scientists 2026 revealed!
Award Badge
Biology and Biochemistry
Spain
2023
Award Badge
Medicine
Spain
2023

D-Index & Metrics

Medicine

D-Index
108
Citations
37869
World Ranking
6057
National Ranking
85

Research.com Recognitions

  • 2023 - Research.com Biology and Biochemistry in Spain Leader Award
  • 2023 - Research.com Medicine in Spain Leader Award

Overview

Jesús Prieto is affiliated with the University of Navarra in Spain and has a research focus spanning biochemistry, genetics, molecular biology, and medicine. Their work involves significant contributions to molecular biology and genetics, supported by 28 and 4 publications respectively in these fields.

The specific subfields of study that Prieto has contributed to include molecular biology, genetics, surgery, epidemiology, and cell biology. Their research topics cover diverse areas such as virus-based gene therapy research, pediatric hepatobiliary diseases and treatments, liver disease diagnosis and treatment, glycosylation and glycoproteins research, proteoglycans and glycosaminoglycans research, RNA modifications and cancer, and metabolism and genetic disorders.

Frequent publication venues highlight a range of platforms, including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • UNC Libraries
  • Zenodo (CERN European Organization for Nuclear Research)
  • Current Opinion in Gastroenterology
  • Theranostics

Among recent papers authored or co-authored by Prieto are:

  • Primary biliary cholangitis: pathogenic mechanisms, 2020, Current Opinion in Gastroenterology
  • Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion, 2022, Theranostics
  • Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency-associated hypertransaminasemia, 2022, Hepatology
  • Identifying Differentially Expressed MicroRNAs, Target Genes, and Key Pathways Deregulated in Patients with Liver Diseases, 2020, International Journal of Molecular Sciences
  • Recombinant porphobilinogen deaminase targeted to the liver corrects enzymopenia in a mouse model of acute intermittent porphyria, 2022, Science Translational Medicine

Jesús Prieto collaborates frequently with other researchers including Marta Alonso-Peña, Elisa Herráez, Luís Bujanda, María J. Monte, and Manuela González-Aparicio, each with multiple joint publications. This network of co-authors supports varied investigations primarily related to liver diseases and molecular mechanisms underlying genetic and metabolic disorders.

Best Publications

  • A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C.

    Bruno Sangro;Carlos Gomez-Martin;Manuel de la Mata;Mercedes Iñarrairaegui

  • Phase I Trial of Intratumoral Injection of an Adenovirus Encoding Interleukin-12 for Advanced Digestive Tumors

    Bruno Sangro;Guillermo Mazzolini;Juan Ruiz;Maite Herraiz

  • Immunological landscape and immunotherapy of hepatocellular carcinoma

    Jesús Prieto;Ignacio Melero;Bruno Sangro

  • New therapies for hepatocellular carcinoma.

    M A Avila;C Berasain;B Sangro;J Prieto

  • Inflammation and liver cancer: new molecular links .

    C. Berasain;J. Castillo;M.J. Perugorria;M.U. Latasa

  • Serum ferritin in patients with iron overload and with acute and chronic liver diseases.

    J. Prieto;Michael Barry;Sheila Sherlock

  • A combinatorial approach to create artificial homing endonucleases cleaving chosen sequences

    Julianne Smith;Sylvestre Grizot;Sylvain Arnould;Aymeric Duclert

  • Lysophosphatidic Acid Is a Potential Mediator of Cholestatic Pruritus

    Andreas E. Kremer;Job J.W.W. Martens;Wim Kulik;Franziska Ruëff

  • Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma.

    Matías A Avila;Carmen Berasain;Luis Torres;Antonio Martín-Duce

  • Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C

    E Larrea;N Garcia;C Qian;M P Civeira

  • CD4+/CD25+ Regulatory Cells Inhibit Activation of Tumor-Primed CD4+ T Cells with IFN-γ-Dependent Antiangiogenic Activity, as well as Long-Lasting Tumor Immunity Elicited by Peptide Vaccination

    Noelia Casares;Laura Arribillaga;Pablo Sarobe;Javier Dotor

  • Prognostic factors and prevention of radioembolization‐induced liver disease

    Belen Gil-Alzugaray;Ana Chopitea;Mercedes Iñarrairaegui;Jose I. Bilbao

  • Mitochondrial Cholesterol Contributes to Chemotherapy Resistance in Hepatocellular Carcinoma

    Joan Montero;Albert Morales;Laura Llacuna;Josep M. Lluis

  • Engineering of large numbers of highly specific homing endonucleases that induce recombination on novel DNA targets.

    Sylvain Arnould;Patrick Chames;Christophe Perez;Emmanuel Lacroix

  • Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma

    Bruno Sangro;Jose I. Bilbao;Jose Boan;Antonio Martinez-Cuesta

  • Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients.

    Iván Peñuelas;Guillermo Mazzolini;José F. Boán;Bruno Sangro

  • Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis.

    J. F. Medina;E. Martinez-Anso;J. Jaime Vazquez;J. Prieto

  • Transmission of hepatitis C virus infection to tree shrews.

    Zhi-Chun Xie;Jose-Ignacio Riezu-Boj;Juan-Jose Lasarte;Javier Guillen

  • Up‐regulation of microRNA 506 leads to decreased Cl−/HCO3− anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis

    Jesús M. Banales;Jesús M. Banales;Jesús M. Banales;Elena Sáez;Miriam Úriz;Sarai Sarvide

  • Intratumoral Injection of Dendritic Cells Engineered to Secrete Interleukin-12 by Recombinant Adenovirus in Patients With Metastatic Gastrointestinal Carcinomas

    Guillermo Mazzolini;Carlos Alfaro;Bruno Sangro;Esperanza Feijoó

Frequent Co-Authors

Bruno Sangro
Bruno Sangro University of Navarra
Juan José Lasarte
Juan José Lasarte University of Navarra
Ignacio Melero
Ignacio Melero University of Oxford
Matías A. Avila
Matías A. Avila University of Navarra
Sandra Hervas-Stubbs
Sandra Hervas-Stubbs University of Navarra
José M. Mato
José M. Mato CIC bioGUNE
Stefan Kochanek
Stefan Kochanek University of Ulm
Francisco Guarner
Francisco Guarner Autonomous University of Barcelona
Jose J.G. Marin
Jose J.G. Marin University of Salamanca
Ronald P.J. Oude Elferink
Ronald P.J. Oude Elferink University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens the door to various online degree options and career routes in healthcare. For those aspiring to advance in healthcare administration, enrolling in one of the top online mha programs that are cahme accredited ensures you receive high-quality education respected by employers.

Current nurses seeking career advancement without additional on-site training may be interested in rn to bsn online with no clinicals programs. These pathways offer flexibility while eliminating clinical requirements for working nurses.

If you’re aiming for a terminal nursing degree, both short dnp programs and online dnp programs without clinicals provide fast, accessible options for advanced practice nurses. These degrees can broaden your professional reach or facilitate roles in leadership and education.

Online degrees help meet career goals with the flexibility needed by today’s healthcare professionals. Each program type has distinct advantages—research your options carefully to find the best fit for your journey in medicine or healthcare leadership.

Best Scientists Citing Jesús Prieto

Trending Scientists